Stimulation of the Larynx to Treat Unexplained Chronic Cough
Purpose
Researchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
Condition
- Cough
Eligibility
- Eligible Ages
- Between 18 Years and 88 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Adults aged 18-88 - >8 weeks of cough - Cough visual analogue scale (VAS): Rating of 30 or greater on a 0-100 cough severity scale - Ability to provide informed consent and independently complete questionnaires - Ability to read and speak English
Exclusion Criteria
- Electronic implants (e.g., pacemaker) - Currently doing speech therapy for cough - Contraindications to safe or effective VTS device use - No regular access to wifi internet Neuromuscular impairment that may affect cough/laryngeal sensation and/or function (e.g., multiple system atrophy, Parkinson, CVA, vocal fold paralysis or paresis) - Untreated carotid disease - BMI > 40 (for transmission of VTS through soft tissue) - Current or recent (quit < 3 months ago) smoking - Known currently infectious cause for cough (e.g., TB, pertussis, COVID) - History of known or suspected aspiration pneumonia - Diagnosis or clinical suspicion of chronic obstructive pulmonary disease (COPD) - Diagnosis or clinical suspicion of interstitial lung disease (ILD) - Unmanaged reflux - Unmanaged allergies/postnasal drip
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Vibrotactile Stimulation |
|
Recruiting Locations
Minneapolis 5037649, Minnesota 5037779 55455
More Details
- NCT ID
- NCT05273190
- Status
- Recruiting
- Sponsor
- University of Minnesota
Study Contact
Clinical Research Coordinators Ashley Ramaker, MS or colleagues612-625-3278
coughstudy@umn.edu